KRAS MUTATIONS IN PATIENTS WITH NONSQUAMOUS NON-SMALL-CELL LUNG CANCER: PREVALENCE AND RELATIONSHIP WITH PD-L1 EXPRESSION, TUMOR MUTATION BURDEN AND SMOKING STATUS

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPGARASSINO, Marina ChiaraRODRIGUEZ-ABREU, DelvysGADGEEL, Shirish M.KOWALSKI, Dariusz M.KASAHARA, KazuoFELIP, EnriquetaWU, Yi-LongCASTRO, Gilberto deCHO, Byoung ChulTURNA, Hande Z.HORINOUCHI, HidehitoRECK, MartinHUI, RinaGARON, Edward B.BOYER, MichaelMOK, Tony S. K.LOPES, GilbertoKOBIE, JulieLI, YongjinAYERS, Mark A.CRISTESCU, RazvanZHAO, BinPIETANZA, M. CatherineHERBST, Roy S.2022-07-222022-07-222021JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, suppl.2, p.A391-A391, 2021https://observatorio.fm.usp.br/handle/OPI/47623engopenAccessKRAS MUTATIONS IN PATIENTS WITH NONSQUAMOUS NON-SMALL-CELL LUNG CANCER: PREVALENCE AND RELATIONSHIP WITH PD-L1 EXPRESSION, TUMOR MUTATION BURDEN AND SMOKING STATUSconferenceObjectCopyright BMJ PUBLISHING GROUP10.1136/jitc-2021-SITC2021.364OncologyImmunology2051-1426